Showing results (101-110 of 372) with videos related to
Sort By:
Pageof 38
European Journal of Immunology|February 8, 2019
Protection from EAE in DOCK8 mutant mice occurs despite increased Th17 cell frequencies in the peripheryAlicia S Wilson, Hsei Di Law, Christiane B Knobbe-Thomsen, et al.The Journal of Clinical Investigation|November 2, 2012
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cellsAnne Brüstle, Dirk Brenner, Christiane B Knobbe, et al.Acta Neurochirurgica|December 31, 2014
5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapyMarcel A Kamp, Jörg Felsberg, Hosai Sadat, et al.Journal of Neuro-Oncology|October 21, 2009
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT statusDelia Kurzwelly, Martin Glas, Patrick Roth, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 28, 2009
Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathyNicola Palomero-Gallagher, Hans-Jürgen Bidmon, Markus Cremer, et al.Cancer Research|August 17, 2005
Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningiomaEriks A Lusis, Mark A Watson, Michael R Chicoine, et al.BMC Cancer|December 19, 2009
ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and gliomaSilke Götze, Valeska Feldhaus, Thilo Traska, et al.Cancer Science|December 15, 2010
Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomasBenito Campos, Justo Lorenzo Bermejo, Lin Han, et al.Neuro-Oncology|October 26, 2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practiceMichael Weller, Roger Stupp, Monika E Hegi, et al.Journal of Magnetic Resonance Imaging : JMRI|October 27, 2004
Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?Dirk Pauleit, Karl-Josef Langen, Frank Floeth, et al.Pageof 38